Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT06993194
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18 years or older
* Confirmed diagnosis of traumatic brain injury
* Admission to the intensive care unit
* Currently receiving mechanical ventilation
* Richmond Agitation-Sedation Scale score between -5 and +4
* At least 48 hours have passed since ICU admission
Exclusion Criteria:
* Pre-existing neurological or psychiatric disorders (e.g., schizophrenia, bipolar disorder)
* Known allergy or contraindication to haloperidol or dexmedetomidine
* Significant hepatic or renal dysfunction
* Pregnant or breastfeeding women
* History of prolonged QT interval or other cardiac arrhythmias
* Use of long-term antipsychotic or sedative medications before ICU admission
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06993194
Study Brief:
Protocol Section:
NCT06993194